Person having heterozygous sickle cell trait is protected from infection of-
## **Core Concept**
The sickle cell trait, also known as sickle cell heterozygous state, is a condition where an individual has one normal hemoglobin gene (HbA) and one sickle cell gene (HbS). This results in the production of both normal hemoglobin and abnormal sickle hemoglobin. The underlying principle here involves the relationship between sickle cell trait and resistance to certain infections, notably malaria.
## **Why the Correct Answer is Right**
Individuals with the sickle cell trait (HbAS) have been found to have a selective advantage against malaria, particularly that caused by *Plasmodium falciparum*. The sickling of red blood cells under low oxygen conditions creates an environment that is less favorable for the growth and survival of the malaria parasite. This protection is thought to be the reason for the higher prevalence of the sickle cell allele in areas where malaria is or was historically prevalent.
## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is incorrect because there is no well-established link between sickle cell trait and protection against infections like typhoid fever that would make it a standout correct answer in this context.
- **Option B:** Similarly, this option does not directly relate to a commonly recognized protection associated with the sickle cell trait.
- **Option C:** This is the correct answer, *Plasmodium falciparum*, as explained.
- **Option D:** This option does not specify a pathogen and is therefore not directly relevant to the question of protection against a specific infection.
## **Clinical Pearl / High-Yield Fact**
A key point to remember is that individuals with sickle cell trait have increased resistance to malaria, particularly *Plasmodium falciparum*. However, they can still get malaria, and the disease can be severe. This protection is one of the reasons for the genetic polymorphism of sickle cell disease in populations from malaria-endemic areas.
## **Correct Answer:** C. Plasmodium falciparum.